It is easy to see, but it is better to foresee: a case report on the favourable alliance between CardioMEMS and levosimendan.

Valeria ViscoCristina EspositoPaolo VitilloCarmine VecchioneMichele Ciccarelli

Published in: European heart journal. Case reports (2020)

Our case supports the combination of CardioMEMS and levosimendan for the optimal management of patients with advanced HF. These results further strengthen the development of a randomized clinical trial to demonstrate the clinical usefulness of this device in combination with the levosimendan infusion programme in advanced HF patients.

Keyphrases

cardiac surgery
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
low dose
study protocol
acute heart failure